DNAzymes to mouse β1 integrin mRNA in vivo: targeting the tumor vasculature and retarding cancer growth.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 9, p. 713, doi. 10.1038/cgt.2009.13
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2009 AND VI 16 AND IP 9
Results: 7
1
2
Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 9, p. 703, doi. 10.1038/cgt.2009.12
- By:
- Publication type:
- Article
3
Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibition.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 9, p. 693, doi. 10.1038/cgt.2009.14
- By:
- Publication type:
- Article
4
Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 9, p. 673, doi. 10.1038/cgt.2009.17
- By:
- Publication type:
- Article
5
Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 9, p. 723, doi. 10.1038/cgt.2009.19
- By:
- Publication type:
- Article
6
Combined inhibition of PAK7, MAP3K7 and CK2α kinases inhibits the growth of MiaPaCa2 pancreatic cancer cell xenografts.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 9, p. 731, doi. 10.1038/cgt.2009.22
- By:
- Publication type:
- Article
7
MLH1 deficiency enhances tumor cell sensitivity to ganciclovir.
- Published in:
- Cancer Gene Therapy, 2009, v. 16, n. 9, p. 683, doi. 10.1038/cgt.2009.16
- By:
- Publication type:
- Article